Suppr超能文献

小儿遗传性球形红细胞增多症中的胆道梗阻:16例临床回顾

Biliary obstruction in pediatric hereditary spherocytosis: a clinical review of 16 cases.

作者信息

Huang Xinjie, Peng Chunhui, Chen Yajun, Wu Dongyang, Chen Wei, Wang Zengmeng, Wang Kai

机构信息

Department of General Surgery, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, No. 56 Nanlishi Road, Beijing, 100045, China.

Department of Pediatric Surgery, Beijing Tsinghua Changgung Hospital, No.168 Litang Road, Beijing, 102218, China.

出版信息

BMC Pediatr. 2025 May 19;25(1):404. doi: 10.1186/s12887-025-05760-z.

Abstract

BACKGROUND

Biliary obstruction is a rare complication in patients with hereditary spherocytosis (HS). The clinical course and optimal treatment strategies for HS patients complicated by biliary obstruction remain unclear.

METHODS

We conducted a retrospective review of 16 pediatric HS patients complicated by biliary obstruction who were treated at our hospital between January 2018 and October 2024. Based on previously published clinical severity classifications, patients were divided into Group A (non-severe group: trait, mild, and moderate) and Group B (severe group).

RESULTS

The study included 16 patients with a mean age of 9.0 ± 3.2 years, evenly distributed between the two groups (8 patients each). Preoperative routine blood tests showed no significant differences between the groups; however, Group B exhibited higher bilirubin levels and lower liver enzyme levels. Genetic testing was performed in 12 patients, revealing SPTB gene mutations in 7 (58.3%). Conservative management effectively resolved biliary obstruction in 10 patients (62.5%) within 14 days. Invasive interventions, such as endoscopic retrograde cholangiopancreatography (ERCP) or cholecystostomy, were required in 6 patients, with conjugated bilirubin levels normalizing within five days post-procedure. Complications occurred in two patients with prolonged intervals between diagnosis and surgery (> 3 months): one required stent replacement due to blockage after ERCP, and the other developed a gallbladder-skin fistula and coagulation disorder following laparoscopic cholecystostomy. Of the 14 patients who underwent subsequent splenectomy and/or cholecystectomy, 12 recovered without complications. Notably, the 6 patients who underwent splenectomy alone without cholecystectomy did not experience biliary colic during a mean follow-up period of 3.4 years (range: 0.5 - 5.5 years).

CONCLUSIONS

Biliary obstruction can complicate HS in pediatric patients regardless of anemia severity, particularly in those with SPTB gene mutations. Conservative management is effective in most cases, while invasive procedures are required for refractory cases. Shortening the interval between diagnosis and subsequent surgery may help prevent complications. Splenectomy alone appears to be a viable option once biliary obstruction is resolved.

摘要

背景

胆道梗阻是遗传性球形红细胞增多症(HS)患者中一种罕见的并发症。HS合并胆道梗阻患者的临床病程及最佳治疗策略仍不明确。

方法

我们对2018年1月至2024年10月在我院接受治疗的16例合并胆道梗阻的儿科HS患者进行了回顾性研究。根据先前发表的临床严重程度分类,将患者分为A组(非严重组:特征型、轻度和中度)和B组(严重组)。

结果

该研究纳入16例患者,平均年龄9.0±3.2岁,两组患者数量均衡(每组8例)。术前常规血液检查显示两组之间无显著差异;然而,B组的胆红素水平较高,肝酶水平较低。对12例患者进行了基因检测,其中7例(58.3%)检测到SPTB基因突变。保守治疗使10例患者(62.5%)在14天内有效缓解了胆道梗阻。6例患者需要进行侵入性干预,如内镜逆行胰胆管造影(ERCP)或胆囊造瘘术,术后5天内结合胆红素水平恢复正常。2例诊断与手术间隔时间较长(>3个月)的患者出现了并发症:1例患者因ERCP后堵塞需要更换支架,另1例患者在腹腔镜胆囊造瘘术后出现胆囊皮肤瘘和凝血障碍。在随后接受脾切除术和/或胆囊切除术的14例患者中,12例康复且无并发症。值得注意的是,6例仅接受脾切除术而未行胆囊切除术的患者在平均3.4年(范围:0.5 - 5.5年)的随访期内未出现胆绞痛。

结论

无论贫血严重程度如何,胆道梗阻都可能使儿科HS患者病情复杂化,尤其是那些存在SPTB基因突变的患者。在大多数情况下,保守治疗是有效的,而难治性病例则需要进行侵入性手术。缩短诊断与后续手术之间的间隔时间可能有助于预防并发症。一旦胆道梗阻得到解决,单纯脾切除术似乎是一个可行的选择。

相似文献

1
Biliary obstruction in pediatric hereditary spherocytosis: a clinical review of 16 cases.
BMC Pediatr. 2025 May 19;25(1):404. doi: 10.1186/s12887-025-05760-z.
2
A de novo ANK1 mutation in a childhood hereditary spherocytosis: a case report.
BMC Pediatr. 2023 May 29;23(1):267. doi: 10.1186/s12887-023-04092-0.
3
[Clinical and genotypic analysis of hereditary spherocytosis combined with cholestasis among pediatric patients].
Zhonghua Gan Zang Bing Za Zhi. 2023 Sep 20;31(9):943-946. doi: 10.3760/cma.j.cn501113-20230210-00048.
4
The role of prophylactic cholecystectomy during splenectomy in children with hereditary spherocytosis.
J Pediatr Surg. 1999 Jul;34(7):1077-8. doi: 10.1016/s0022-3468(99)90569-9.
6
Hereditary spherocytosis: Retrospective evaluation of 65 children.
Turk J Pediatr. 2018;60(3):264-269. doi: 10.24953/turkjped.2018.03.005.
8
Hereditary spherocytosis complicated by intrahepatic cholestasis: two case reports.
Ann Transl Med. 2022 Nov;10(22):1255. doi: 10.21037/atm-22-5076.
9
Mutational characteristics of ANK1 and SPTB genes in hereditary spherocytosis.
Clin Genet. 2016 Jul;90(1):69-78. doi: 10.1111/cge.12749. Epub 2016 Mar 15.
10
Clinical and genetic characteristics of Chinese pediatric and adult patients with hereditary spherocytosis.
Orphanet J Rare Dis. 2024 Jul 24;19(1):278. doi: 10.1186/s13023-024-03290-y.

本文引用的文献

1
Cholecystectomy Is a Risk Factor for Proximal Colon Cancer That May Also Relate to its Aggressiveness.
J Surg Res. 2024 Dec;304:152-161. doi: 10.1016/j.jss.2024.10.018. Epub 2024 Nov 15.
2
"Surgery First" vs. "Endoscopy First" for Pediatric Choledocholithiasis Presenting at the End of the Week - A CARES Working Group Study.
J Pediatr Surg. 2025 Jan;60(1):161959. doi: 10.1016/j.jpedsurg.2024.161959. Epub 2024 Sep 24.
3
Multi-Institutional Analysis of Choledocholithiasis in Pediatric vs Adult Patients.
J Pediatr Surg. 2024 Dec;59(12):161661. doi: 10.1016/j.jpedsurg.2024.08.001. Epub 2024 Aug 13.
4
No association between cholecystectomy and risk of colorectal cancer: a meta-analysis of cohort studies.
Int J Colorectal Dis. 2023 Jun 27;38(1):179. doi: 10.1007/s00384-023-04463-0.
5
A de novo ANK1 mutation in a childhood hereditary spherocytosis: a case report.
BMC Pediatr. 2023 May 29;23(1):267. doi: 10.1186/s12887-023-04092-0.
6
Treatment of asymptomatic gallstones in children with hereditary spherocytosis requiring splenectomy.
J Pediatr Surg. 2023 Apr;58(4):756-761. doi: 10.1016/j.jpedsurg.2022.11.012. Epub 2022 Nov 25.
7
Hereditary spherocytosis complicated by intrahepatic cholestasis: two case reports.
Ann Transl Med. 2022 Nov;10(22):1255. doi: 10.21037/atm-22-5076.
10
Choledocholithiasis-a new clinical pathway.
Transl Gastroenterol Hepatol. 2021 Jul 25;6:35. doi: 10.21037/tgh-20-172. eCollection 2021.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验